We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Peptide Medication Breakthrough

News   Feb 22, 2018 | Original story from Technical University of Munich

 
Peptide Medication Breakthrough

Cyclic hexapeptide in its bioactive form with the integrin-binding tripeptide sequence arginine-glycine-aspartic acid: Green spheres represent carbon atoms, red oxygen atoms, blue nitrogen atoms and white hydrogen atoms. Yellow spheres represent the two N-methyl groups and dashed orange lines show the two intramolecular hydrogen bonds. Arrangement (clockwise): arginine (top), glycine, aspartic acid, alanine, N-methylated alanine, N-methylated D-valine. Credit: Michael Weinmueller / TUM

 
 
 

RELATED ARTICLES

A Grand Plan to Target Cause of Alzheimer's Disease

News

A breakthrough has been made in the fight against Alzheimer's disease - researchers have found a new way to target the toxic particles that destroy healthy brain cells. Academics have devised the first strategy to 'go after' the cause of the devastating disease, leading to hope that new drugs could be developed to treat dementia.

READ MORE

Drug Blocks Pancreatic Cancer Growth in Mice

News

A newly developed drug can prevent the most common type of pancreatic cancer from growing and spreading in laboratory mice, according to a new study.

READ MORE

Rare and Undiagnosed Conditions Get Massive Research Funding Boost

News

Five new clinical sites, a new metabolomics core, and increased model organism capabilities among additions.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE